A new Ebola testing machine is installed in the laboratory of Mongbwalu General Referral Hospital in Ituri eprovince, DR Congo. The equipment allows samples to be tested on site, reducing the need to transport them to Bunia and helping teams obtain results more quickly during the Ebola response.

Photo Credit: Anna Schönhofer/MSF

08 June 2026

Principles for equitable access to medical tools for Ebola disease caused by Bundibugyo virus

MSF calls for following R&D Principles for equitable access to medical tools for Bundibugyo virus

RESEARCH AND DEVELOPMENT

Photo Credit: Anna Schönhofer/MSF

Statement |

16 June 2026

Europe

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Press release |

16 June 2026

Public investment demands public benefits: European Biotech Act must deliver for people

Events |

18 May 2026

MSF statements at WHO World Health Assembly 79th session

Statement |

18 May 2026

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Statement |

18 May 2026

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Statement |

18 May 2026

Immunization Agenda 2030 – WHA79/12.3

Statement |

18 May 2026

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Press release |

18 May 2026

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

Statement |

18 May 2026

WHO’s work in health emergencies – WHA79/ 14.1

Press release |

15 May 2026

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

Statement |

06 May 2026

MSF Access welcomes Kris Torgeson as incoming Executive Director

Letter |

17 April 2026

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Salah Aldeen - nurse – places an intravenous line to Marwa, 3 years. Marwa was admitted the day before, as she was presenting common symptoms of measles. Amir, her big brother, who lies in the next tent, was admitted 5 days earlier for the same reason.

Photo Credit: Thibault Fendler/MSF

Press release |

18 May 2026

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile areas

VACCINES

Photo Credit: Thibault Fendler/MSF

Statement |

16 June 2026

Europe

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Press release |

16 June 2026

Public investment demands public benefits: European Biotech Act must deliver for people

Events |

18 May 2026

MSF statements at WHO World Health Assembly 79th session

Statement |

18 May 2026

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Statement |

18 May 2026

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Statement |

18 May 2026

Immunization Agenda 2030 – WHA79/12.3

Statement |

18 May 2026

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Statement |

18 May 2026

WHO’s work in health emergencies – WHA79/ 14.1

Press release |

15 May 2026

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

Statement |

06 May 2026

MSF Access welcomes Kris Torgeson as incoming Executive Director

Letter |

17 April 2026

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Report |

09 April 2026

AfricaKenyaRwandaSouth Africa

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab.

Photo Credit: Gul Nayab

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

1.2 million children have TB worldwide, but nearly half miss diagnosis and treatment

TUBERCULOSIS

Photo Credit: Gul Nayab

Statement |

16 June 2026

Europe

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Press release |

16 June 2026

Public investment demands public benefits: European Biotech Act must deliver for people

Events |

18 May 2026

MSF statements at WHO World Health Assembly 79th session

Statement |

18 May 2026

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Statement |

18 May 2026

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Statement |

18 May 2026

Immunization Agenda 2030 – WHA79/12.3

Statement |

18 May 2026

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Press release |

18 May 2026

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

Statement |

18 May 2026

WHO’s work in health emergencies – WHA79/ 14.1

Press release |

15 May 2026

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

Statement |

06 May 2026

MSF Access welcomes Kris Torgeson as incoming Executive Director

Letter |

17 April 2026

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health.

Photo credit: MSF/Martim Gray Pereira

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

EU must guarantee access to medical tools for communities sharing pathogens and data

PANDEMIC PREPAREDNESS RESEARCH AND DEVELOPMENT

European Union

Photo credit: MSF/Martim Gray Pereira

Statement |

16 June 2026

Europe

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Press release |

16 June 2026

Public investment demands public benefits: European Biotech Act must deliver for people

Events |

18 May 2026

MSF statements at WHO World Health Assembly 79th session

Statement |

18 May 2026

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Statement |

18 May 2026

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Statement |

18 May 2026

Immunization Agenda 2030 – WHA79/12.3

Statement |

18 May 2026

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Press release |

18 May 2026

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

Statement |

18 May 2026

WHO’s work in health emergencies – WHA79/ 14.1

Press release |

15 May 2026

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

Statement |

06 May 2026

MSF Access welcomes Kris Torgeson as incoming Executive Director

Letter |

17 April 2026

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Latest News

Photograph by James Keogh/Wostok Press

09 May 2017

Privacy and personal data protection policy

Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi

Photograph by Siddharth Singh

Press release

Press release |

08 May 2017

Intellectual property and trade

IndiaPhilippines

MSF response on RCEP negotiations in the Philippines

4 min

Photograph by Siddharth Singh

Opinion article

Opinion article |

05 May 2017

Intellectual property and trade

IndiaPhilippinesASEAN

Intellectual property, affordable medicine, and universal health care

4 min

In New York, on Word Pneumonia Day 2015 (Nov 12), MSF volunteers attempted to deliver more than $17 million of fake cash - the equivalent of one day of profits from the pneumonia vaccines for Pfizer globally - to Pfizer's CEO Ian Read. The same day, MSF launched a global petition to ask Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumococcal vaccine to $5 dollars per child (for all three doses) in developing countries. Credit: Edwin Torres.

Photograph by Edwin Torres

Press release

Press release |

27 April 2017

Vaccines

Investors join MSF in calling Pfizer to reduce the price of vaccine against top childhood killer

Photograph by Sandra Smiley

Press release

Press release |

26 April 2017

Vaccines

Study: Replacing existing vaccines with heat-stable versions saves money, protects more mothers and children from deadly diseases

5 min

Vials of PCV13, a vaccine that protects children against pneumonia and meningitis. At 9 Euros a dose (three doses are necessary for the vaccine to be effective) PCV13 is currently priced at a rate much higher than most people in Central African Republic can afford. Photograph by Sandra Smiley

Photograph by Sandra Smiley

Press release

Press release |

25 April 2017

US Department of Defense announces decision to give pharmaceutical corporation exclusive rights on taxpayer-funded Zika vaccine

Children queue at a vaccination point in the commune of Matoto, Conakry, Guinea. Médecins Sans Frontières/Doctors without Borders (MSF) is launching a large scale measles vaccination campaign in Conakry, the capital of Guina. Since the beginning of the year there have been 3468 confirmed cases and 14 deaths dues to measles in Guinea. Conakry and Nzérékoré are the most affected districts. Photograph by Markel Redondo

Photograph by Markel Redondo

Feature story

Feature story |

20 April 2017

Vaccines

Guinea

Guinea – a respite against measles

3 min

Photograph by Vania Alves

Feature story

Feature story |

14 April 2017

Tropical & neglected diseases

On International Chagas Day, MSF asks the Bolivian government to increase the resources allocated to fight the disease

5 min

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Video |

14 April 2021

100 years of insulin

Video

A Snapshot of the Access Campaign

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

100 years of insulin

A Snapshot of the Access Campaign

Our work

COVID-19

Drug-resistant infections

Diabetes

Hepatitis C

HIV/AIDS

Tropical & neglected diseases

Tuberculosis

Vaccines

Patents & intellectual property

Research & development

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Public investment demands public benefits: European Biotech Act must deliver for people

MSF statements at WHO World Health Assembly 79th session

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Immunization Agenda 2030 – WHA79/12.3

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

WHO’s work in health emergencies – WHA79/ 14.1

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

MSF Access welcomes Kris Torgeson as incoming Executive Director

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Public investment demands public benefits: European Biotech Act must deliver for people

MSF statements at WHO World Health Assembly 79th session

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Immunization Agenda 2030 – WHA79/12.3

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

WHO’s work in health emergencies – WHA79/ 14.1

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

MSF Access welcomes Kris Torgeson as incoming Executive Director

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Shifting Global Health R&D Funding: Opportunities in a Changing Landscape

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Public investment demands public benefits: European Biotech Act must deliver for people

MSF statements at WHO World Health Assembly 79th session

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Immunization Agenda 2030 – WHA79/12.3

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

WHO’s work in health emergencies – WHA79/ 14.1

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

MSF Access welcomes Kris Torgeson as incoming Executive Director

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Public investment demands public benefits: European Biotech Act must deliver for people

MSF statements at WHO World Health Assembly 79th session

Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3

Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1

Immunization Agenda 2030 – WHA79/12.3

Draft updated global action plan on antimicrobial resistance – WHA79/12.9

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

WHO’s work in health emergencies – WHA79/ 14.1

Countries must lay groundwork to turn Pandemic Agreement commitments into access for all

MSF Access welcomes Kris Torgeson as incoming Executive Director

Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement

Latest News

Our work

MSF Access welcomes Kris Torgeson as incoming Executive Director

MSF Access welcomes Kris Torgeson as incoming Executive Director

MSF Access welcomes Kris Torgeson as incoming Executive Director

MSF Access welcomes Kris Torgeson as incoming Executive Director